Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery-Reference-Cited by-同舟云学术

Longitudinal immune characterization of syngeneic tumor models to enable model selection for immune oncology drug discovery

Published:2019-11-28 Issue:1 Volume:7 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Taylor Molly A.^ORCID,Hughes Adina M.,Walton Josephine,Coenen-Stass Anna M. L.,Magiera Lukasz,Mooney Lorraine,Bell Sigourney,Staniszewska Anna D.,Sandin Linda C.,Barry Simon T.,Watkins Amanda,Carnevalli Larissa S.,Hardaker Elizabeth L.

Funder

AstraZeneca

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-019-0794-7.pdf

Reference33 articles.

1. Zitvogel L, Pitt JM, Daillere R, Smyth MJ, Kroemer G. Mouse models in oncoimmunology. Nat Rev Cancer. 2016;16(12):759–73.

2. Tong M, Wang J, He W, Wang Y, Pan H, Li D, et al. Predictive biomarkers for tumor immune checkpoint blockade. Cancer Manag Res. 2018;10:4501–7.

3. Constantinidou A, Alifieris C, Trafalis DT. Targeting programmed cell death −1 (PD-1) and ligand (PD-L1): a new era in cancer active immunotherapy. Pharmacol Ther. 2018;194:84–106.

4. Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014–22.

5. Kvistborg P, Philips D, Kelderman S, Hageman L, Ottensmeier C, Joseph-Pietras D, et al. Anti-CTLA-4 therapy broadens the melanoma-reactive CD8+ T cell response. Sci Transl Med. 2014;6(254):254ra128.

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Validation of the C-X-C chemokine receptor 3 (CXCR3) as a target for PET imaging of T cell activation;EJNMMI Research;2024-08-28

2. Irreversible Electroporation has More Synergistic Effect with Anti‐PD‐1 Immunotherapy than Thermal Ablation or Cryoablation, in a Colorectal Cancer Model;Advanced Therapeutics;2024-08-14

3. OMIP‐105: A 30‐color full‐spectrum flow cytometry panel to characterize the immune cell landscape in spleen and tumor within a syngeneic MC‐38 murine colon carcinoma model;Cytometry Part A;2024-08-06

4. Mapping the genetic landscape establishing a tumor immune microenvironment favorable for anti-PD-1 response in mice and humans;2024-07-16

5. Enhanced Proteomic Coverage in Tissue Microenvironment by Immune Cell Subtype Library-Assisted DIA-MS;Molecular & Cellular Proteomics;2024-07